Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
China
Sort By
Newest First
1 / 2
1 / 2
BIOSECURE Act
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
Pharma's Almanac
PAO-11-24-RT-01
Oct 28, 2024
Drug Supply
BeiGene Announces Supply Update for ABRAXANE in China
BeiGene
PR-M03-20-NI-037
Mar 25, 2020
Drug Development
WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers
WuXi Biologics
PR-M11-19-NI-018
Nov 19, 2019
China
GE Healthcare Life Sciences and Akeso Pharmaceuticals to Speed Up Novel Therapy Manufacturing in China
Nice Insight
PR-M11-19-NI-015
Nov 15, 2019
Strategic Collaboration
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
Amgen
PR-M10-19-NI-048
Nov 01, 2019
R&D
Covance Unveils New R&D Center in Shanghai
LabCorp
PR-M09-19-NI-038
Sep 16, 2019
M&A
Zhejiang Jiuzhou to Acquire Suzhou Unit of Novartis AG for CNY790 Million
Nice Insight
PAO-M09-19-NI-009
Sep 05, 2019
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
Innovent
PR-M08-19-NI-076
Aug 27, 2019
Collaboration
iBio and CC-Pharming Expand Business Collaboration in China
iBio, Inc.
PR-M08-19-NI-087
Aug 26, 2019
Research
Hybrid Human/Monkey Embryos Created by Salk Researchers in China
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-027
Aug 22, 2019
Drug Pricing
China Welcomes Indian Competition in Push to Lower Drug Costs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-010
Aug 07, 2019
Generics
China Eases Generic Drug Market Shake-Up
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-001
Aug 01, 2019
Biosimilars
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
Celltrion, Inc.
PR-M07-19-NI-058
Jul 23, 2019
Gene Editing
China to Introduce Regulations on Gene Editing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-031
May 29, 2019
Consumer Healthcare
GSK and Pfizer’s Combined Consumer Healthcare Business Will Focus on the U.S. and China
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-016
Apr 10, 2019
Oncology Drugs
China Cancer Drugs Market 2018-2024: Rising Demand of Targeted Drug Therapy and the Patent Expiration of Key Cancer Drugs
ResearchandMarkets
PR-M01-19-NI-044-3143
Jan 16, 2019
New Facility
Pall Opens Center of Excellence in Shanghai
Pall Corporation
PR-M12-18-NI-080
Dec 27, 2018
Immunotherapy
I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy
I-Mab
PR-M11-18-NI-014
Nov 05, 2018
Investment
Foreign Investment: Chinese Capital Backs U.S. Biotech
Emilie Branch
Pharma's Almanac
PAP-Q4-18-NI-008
Oct 26, 2018
New Drug Application
AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
Aveo Oncology
PR-M09-18-NI-029
Sep 12, 2018
